{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:03:57Z","timestamp":1792717437620,"version":"4.5.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:p>New options recently became available for treatment of uncontrolled blood pressure. Information on the prevalence of therapy-resistant hypertension (TRH) in patients with chronic kidney disease and its consequences is relevant to balance risks and benefits of potential new therapies. Data of 788 patients with chronic kidney disease came from a multicenter study investigating the effect on outcome of an integrated multifactorial approach delivered by nurse practitioners added to usual care versus usual care alone. Blood pressure was measured at the office and during 30 minutes using an automated oscillometric device. Apparent TRH (aTRH) was defined as a blood pressure \u2265130\/80 mm Hg despite treatment with \u22653 antihypertensive drugs, including a diuretic or treatment with \u22654 antihypertensive drugs. Participants were followed up for the occurrence of myocardial infarction, stroke or cardiovascular mortality (composite cardiovascular end point) and end-stage renal disease. aTRH was present in 34% (office blood pressure) and in 32% (automated measurements). During 5.3 years of follow-up, 17% of patients with aTRH reached a cardiovascular end point and 27% reached end-stage renal disease. aTRH lead to a 1.5-fold higher risk (95% confidence interval, 0.8\u20133.0) of a cardiovascular end point compared with controlled hypertensives in multivariable-adjusted analysis. aTRH increased end-stage renal disease risk 2.3-fold (95% confidence interval, 1.4\u20133.7). During 4 years of follow-up, the prevalence of aTRH did not decline in either treatment group. The prevalence of aTRH is high in patients with chronic kidney disease even after optimization of nephrologist care. The presence of TRH is related to a substantially increased risk of renal and cardiovascular outcomes.<\/jats:p>","DOI":"10.1161\/hypertensionaha.115.05694","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T22:38:57Z","timestamp":1441751937000},"page":"998-1005","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease"],"prefix":"10.1161","volume":"66","author":[{"given":"Esther","family":"de Beus","sequence":"first","affiliation":[{"name":"From the Department of Nephrology and Hypertension (E.d.B., A.D.v.Z., P.J.B.) and Julius Center for Health Sciences and Primary Care (M.L.B.), University Medical Center Utrecht, Utrecht, the Netherlands; and Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands (J.F.M.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel L.","family":"Bots","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Hypertension (E.d.B., A.D.v.Z., P.J.B.) and Julius Center for Health Sciences and Primary Care (M.L.B.), University Medical Center Utrecht, Utrecht, the Netherlands; and Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands (J.F.M.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan D.","family":"van Zuilen","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Hypertension (E.d.B., A.D.v.Z., P.J.B.) and Julius Center for Health Sciences and Primary Care (M.L.B.), University Medical Center Utrecht, Utrecht, the Netherlands; and Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands (J.F.M.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack F.M.","family":"Wetzels","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Hypertension (E.d.B., A.D.v.Z., P.J.B.) and Julius Center for Health Sciences and Primary Care (M.L.B.), University Medical Center Utrecht, Utrecht, the Netherlands; and Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands (J.F.M.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Blankestijn","sequence":"additional","affiliation":[{"name":"From the Department of Nephrology and Hypertension (E.d.B., A.D.v.Z., P.J.B.) and Julius Center for Health Sciences and Primary Care (M.L.B.), University Medical Center Utrecht, Utrecht, the Netherlands; and Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands (J.F.M.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","first-page":"337","article-title":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease.","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2:337\u2013414.","journal-title":"Kidney Int Suppl"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.09.014"},{"key":"e_1_3_4_4_2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.","volume":"43","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2004","unstructured":"Kidney Disease Outcomes Quality Initiative (K\/DOQI). K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:S1\u2013S290.","journal-title":"Am J Kidney Dis"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.260"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00550113"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.12.061"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2014.12.013"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.183459"},{"key":"e_1_3_4_10_2","first-page":"30","article-title":"Rationale and design of the MASTERPLAN study: multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners.","volume":"18","author":"Van Zuilen AD","year":"2005","unstructured":"Van Zuilen AD, Wetzels JF, Blankestijn PJ, Bots ML, Van Buren M, Ten Dam MA, Kaasjager KA, Van De Ven PJ, Vleming LJ, Ligtenberg G, Ligtenberg G; MASTERPLAN Study Group. Rationale and design of the MASTERPLAN study: multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. J Nephrol. 2005;18:30\u201334.","journal-title":"J Nephrol"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.137"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012121222"},{"key":"e_1_3_4_13_2","first-page":"719","article-title":"[Treatment of patients with chronic renal insufficiency; a guideline for internists].","volume":"148","author":"ter Wee PM","year":"2004","unstructured":"ter Wee PM, Jorna AT; Kwaliteitcommissie van de Nederlandse Federatie voor Nefrologie. [Treatment of patients with chronic renal insufficiency; a guideline for internists]. Ned Tijdschr Geneeskd. 2004;148:719\u2013724.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.550"},{"key":"e_1_3_4_15_2","first-page":"229","article-title":"Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease.","volume":"69","author":"van Zuilen AD","year":"2011","unstructured":"van Zuilen AD, Blankestijn PJ, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming L, Bots ML, Wetzels JF. Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease. Neth J Med. 2011;69:229\u2013236.","journal-title":"Neth J Med"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66461-6"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00476-0"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283282f65"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.170308"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.110.168948"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328353634e"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000023"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.068064"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.21.2340"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2014.03.003"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62192-3"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.88"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61942-5"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402670"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03246"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04019"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61272-0"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000221"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.141879"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283577b05"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328363e964"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.115.05694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:51:13Z","timestamp":1715575873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.115.05694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.115.05694"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.115.05694","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725777109.793510548","asserted-by":"object"}]},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"2015-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-08-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-09-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}